Drug Guidance for Subsidy 04/06/2025 Atogepant and rimegepant for prophylaxis of migraine NRThe Ministry of Health’s Drug Advisory Committee has not recommended the following medicatio... See all × 04/06/2025 Atogepant and rimegepant for prophylaxis of migraine NRThe Ministry of Health’s Drug Advisory Committee has not recommended the following medications for inclusion on the MOH List of Subsidised Drugs, due to their uncertain comparative clinical effectiveness and substantially higher prices versus subsidised alternatives: Atogepant for prophylaxis of chronic migraine; and Atogepant or rimegepant for prophylaxis of episodic migraine.